Baiju R. Shah is the President & CEO of Greater Cleveland Partnership, the region’s leading economic development organization and with over 12,000 members, the largest metropolitan chamber of commerce in the nation. Guided by a board of corporate and entrepreneurial CEOs, the organization focuses on accelerating growth and inclusive prosperity through strategic initiatives, business services, real estate, and advocacy.

Prior to GCP, Shah served as the Senior Fellow for Innovation at The Cleveland Foundation, the world’s first community foundation with assets of $2.8 billion. His work centered on catalyzing growth initiatives for the region including leading the Cleveland Innovation Project. Shah remains a member of the Impact Investing Board Committee which directs a $150 million portfolio allocation of the foundation.

Previously, Shah was the CEO of BioMotiv and co-leader of The Harrington Project for Discovery & Development, a national drug development initiative. During his tenure, the company established strategic partnerships with Takeda, Biogen, Bristol-Myers Squibb, AstraZeneca, and Johnson & Johnson. Prior to that, he was CEO and co-founder of BioEnterprise, an accelerator and industry growth initiative formed with Cleveland Clinic, Case Western Reserve University, and University Hospitals of Cleveland.

Shah is a Director of Invacare (NYSE: IVC) and Athersys (NASDAQ: ATHX) and is also a Senior Advisor to FasterCures, a center of the Milken Institute. He also serves as a Trustee of Destination Cleveland and Global Cleveland. Shah began his business career as a consultant with McKinsey & Company.

Shah has been named an Ernst & Young Entrepreneur of the Year and recognized as one of Cleveland’s most influential leaders. He received a JD from Harvard Law School and a BA from Yale University.